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Abstract 
Background: Catheter associated urinary tract infections (CAUTI) are a worldwide problem 
that may lead to  increases patient morbidity, cost and mortality. Accurately estimating the 
effects of CAUTI is difficult because it is a time-dependent exposure. This means that 
standard statistical techniques, such as matched case–control studies, tend to over-estimate 
the increased hospital stay and mortality risk due to infection.  
Objective: To estimate the excess length of stay and mortality in an intensive care unit (ICU) 
due to a CAUTI, using a statistical model that accounts for the timing of infection.  
Design: Cohort of 69,248 admissions followed for 371,452 days in ICU. 
Setting: 29 ICUs in 10 countries: Argentina, Brazil, Colombia, Greece, India, Lebanon, 
Mexico, Morocco, Peru, and Turkey 
Patients: All patients admitted to the ICU during a defined time period with a urinary 
catheter in place for more than 24 hours. 
Methods: To estimate the extra length of stay due to infection we used the methods that 
arrange the data according to the multi-state format. Once a patient has had a urinary catheter 
they may either be discharged or die or they may first become infected. If the time to 
infection is not modelled then this leads to the time-dependent bias. We censored patients 
when it was not known whether they died or were discharged, using a censoring date of their 
last day in ICU. We also censored patients who contracted another unrelated infection (e.g., 
an unrelated blood stream infection) using the date of the unrelated infection. This censoring 
is used to ensure that we estimate the independent effect of urinary tract infection, and not the 
combined effects of multiple infections. We estimated the extra length of stay and increased 
risk of death independently in each country. We then combined the results using a random 
effects meta-analysis. As a sensitivity analysis we also estimated the risks in “healthier” and 
“sicker” patients as determined by the Average Severity Illness Score (ASIS) score. 
Results: A CAUTI prolonged length of ICU stay by an average of 1.59 days (95% CI: 0.58, 
2.59 days), and increased the risk of death by 15% (95% CI: 3, 28%). After stratifying on 
ASIS a CAUTI still led to an increased length of stay, but the increased risk of death only 
remained in the “healthier” subgroup, and was no longer statistically significant. 
Conclusion: A CAUTI leads to a small increased LOS in ICU. The increased risk of death 
due to CAUTI may be due to confounding with patient morbidity. 
 
Introduction 
Catheter associated urinary tract infections (CAUTI) are a worldwide problem that may lead 
to increased patient morbidity, cost and mortality. The literature is divided on whether there 
are real effects from CAUTI on length of stay or mortality. Platt (1982) found the costs and 
mortality risks to be large yet Graves et al. (2007) found the opposite. A review of the 
published estimates of the extra length of stay showed results between zero and 30 days 
(Graves, 2008). This may arise because different epidemiological methods are applied and 
they produce different results. Accurately estimating the effects of CAUTI is difficult 
because it is a time-dependent exposure. This means that standard statistical techniques, such 
as matched case–control studies, tend to over-estimate the increased hospital stay and 
mortality risk due to infection. The aim of the study was to estimate excess length of stay and 
mortality in an intensive care unit (ICU) due to a CAUTI, using a statistical model that 
accounts for the timing of infection. Data collected from ICU units in lower and middle 
income countries were used for this analysis. The research literature is small in these settings 
and this work is novel. 
 
Methods 
We aimed to estimate the impact of infection on both length of stay and risk of death. 
Infection is a time-dependent variable, and so it is essential to use statistical methods that 
correctly account for this, otherwise estimated effects can be severely biased (Beyersmann et 
al 2008, van Walraven et al 2004). Therefore to estimate the extra length of stay due to 
infection we used the methods described in Allignol et al (2010), and to estimate the risk of 
mortality due to infection we used the methods described in Wolkewitz et al (2008).  
Both methods arrange the data according to the multi-state format shown in Figure 1. A 
patient enters the ICU and becomes susceptible to infection after having a urinary catheter. If 
the time to catheter is not modelled then the estimated effects of infection are prone to the 
“length bias” (Wolkewitz et al 2010). Once a patient has had a urinary catheter they may 
either be discharged or die, or they may first become infected. If the time to infection is not 
modelled then this leads to the time-dependent bias (Beyersmann et al 2008). 
We censored patients when it was not known whether they died or were discharged, using a 
censoring date of their last day in ICU. We also censored patients who contracted another 
unrelated infection (e.g., an unrelated blood stream infection) using the date of the unrelated 
infection. This censoring is used to ensure that we estimate the independent effect of urinary 
tract infection, and not the combined effects of multiple infections.  
We estimated the extra length of stay and increased risk of death independently in each 
country. We then combined the results using a random effects meta-analysis. As a sensitivity 
analysis we re-ran the meta-analysis leaving out each country in turn. This analysis assesses 
whether there is a particular country that has a strong influence on the estimated overall 
effect. As another sensitivity analysis we first stratified the admissions according to the 
Average Severity Illness Score (ASIS) score. We estimated the extra length of stay and risk 
of death for admissions in the lower three ASIS categories (“healthier” group), and in the 
upper two categories (“sicker” group). ASIS was not collected in Greece or Lebanon, so they 
were excluded from this sensitivity analysis. 
For all analyses the R 2.4.1 software was used (R Foundation, Vienna, Austria), using the 
‘etm’ library to estimate the extra length of stay due to infection (Allignol, 2009), and the 
‘rmeta’ library for meta-analysis (Lumley 2009). 
 
Results 
Table 1 shows the summary statistics by country. Across all ten countries there were 371,452 
ICU days observed after the patient had a urinary catheter. On average 14% of admissions 
ended in death. 
Table 2 shows the estimated extra LoS and risk of death due to infection by country and the 
meta-analysis summary. On average a UTI infection led to 1.59 extra days in the ICU 
(95% CI: 0.58, 2.59 days) and a 15% increase in the risk of death (95% CI: 3, 28%).  
Figure 2 plots the mean extra length of stay in each country and the meta-analysis. The extra 
length of stay was far longer in Turkey (mean = 5.88 days). The result from Turkey is the 
main driver of the statistically significant heterogeneity in the extra LoS between countries 
(p-value = 0.015). Without Turkey the overall extra LoS drops from an average of 1.59 days 
to 1.11 days. 
Figure 3 plots the mean relative risk of death in each country and the meta-analysis. There 
was more consistency across countries in the relative risk of death compared with the extra 
LoS. The most unusual result was from Colombia, where an infection reduced the relative 
risk to 0.75, although this reduction was not statistically significant (95% CI: 0.47, 1.17). 
Without Colombia the overall relative risk of death rose slightly from 1.15 to 1.18. 
Table 3 shows the results after stratifying on ASIS. The relative risk of death remained high 
in the “healthier” ASIS group (mean RR = 1.16), but the increase was now not statistically 
significant. This lack of statistical significance could be due to a drop in sample size, rather 
than a change in the mean. In the “sicker” ASIS group the mean relative risk of death was 
much closer to one, and the increased risk was no longer statistically significant. The 
estimated extra lengths of stay were similar to the unstratified estimate for both ASIS groups. 
Conclusions 
We used the best available statistical methods to estimate the extra length of stay and risk of 
death due to nosocomial urinary tract infection. These methods treat both the timing of the 
catheter and the timing of infection as time-dependent variables (Figure 1). This means the 
results are not prone to the length bias (which would underestimate the risks of infection), or 
the time-dependent bias (which would overestimate the risks of infection).  
The results were quite consistent between countries and showed a modest increase in the 
extra length of stay due to infection as, on average, there were 1.59 extra days. This increase 
was strongly statistically significant, and had a similar mean after stratifying on ASIS score. 
A relatively small increase in hospital stay still represents an important and potentially costly 
consequence of infection. 
The relative risk for mortality was 1.15 on average, and again this increase was strongly 
statistically significant. However, this strong effect disappeared after stratifying on ASIS 
score. This suggests that the original increased risk was due to confounding by ASIS. We 
know that sicker patients have an increased risk of death, the confounding would be complete 
if sicker patients were also more likely to get urinary tract infections. Clec’h et al (2007) had 
similar findings as they found a statistically significant increased risk of death for patients 
with a UTI that disappeared after matching and adjustment. 
The method we used to estimate the extra LoS and risk of death due to infection is not able to 
adjust for important covariates such as age. However, a recent study by Beyersmann et al 
(2009) demonstrated that adjusting for the timing of infection is likely to be more important 
than adjusting for confounders, as they found that adjusting for 20 potential confounders did 
not redeem the time-dependent bias. 
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Table 1: Sample characteristics by country. All statistics for admissions with a urinary 
catheter, except the Admissions column. 
Country Admissions 
Admissions with 
a catheter (%) 
Length of 
stay, days 
Mean 
age, years
Men (%) Dead (%) 
Argentina 17,910 10,528 (59) 79,788 71 5,231 (29) 2,634 (15)
Brazil 2,452 1,904 (78) 24,074 56 1,054 (43) 520 (21) 
Colombia 8,155 5,480 (67) 44,354 50 2,923 (36) 1,076 (13)
Greece 105 87 (83) 912 66 56 (53) 22 (21) 
India 24,583 17,930 (73) 106,981 55 12,669 (52) 1,951 (8) 
Lebanon 383 378 (99) 3,386 62 266 (69) 81 (21) 
Mexico 3,423 2,187 (64) 15,974 41 919 (27) 359 (10) 
Morocco 2,584 1,435 (56) 12,046 45 740 (29) 660 (26) 
Peru 1,970 1,506 (76) 9,497 53 811 (41) 283 (14) 
Turkey 7,683 5,729 (75) 74,440 50 3,474 (45) 1,909 (25)
Total 69,248 47,164 (68) 371,452 57 28,143 (41) 9,495 (14)
  
Table 2: Estimated extra length of stay (LoS) and relative risk of death due to a nosocomial 
urinary tract infection. Cells show the mean and 95% confidence interval in parenthesis.  
Country  
Total extra  
LoS, days  
Relative risk  
of death 
Argentina 0.90 (0.15, 1.66) 1.26 (1.08, 1.48) 
Brazil 0.95 (–2.71, 4.61) 0.97 (0.60, 1.59) 
Colombia 2.43 (–0.03, 4.89) 0.75 (0.47, 1.17) 
Greece 0.94 (–5.93, 7.81) 1.29 (0.35, 4.70) 
India 2.41 (0.24, 4.58) 1.06 (0.67, 1.67) 
Lebanon –0.83 (–3.83, 2.17) 1.40 (0.56, 3.46) 
Mexico 2.46 (0.49, 4.43) 1.07 (0.66, 1.73) 
Morocco 1.39 (–0.28, 3.05) 1.19 (0.79, 1.81) 
Peru –0.33 (–2.08, 1.42) 0.77 (0.36, 1.64) 
Turkey 5.88 (3.18, 8.58) 1.13 (0.90, 1.43) 
Meta-analysis 1.59 (0.58, 2.59) 1.15 (1.03, 1.28) 
Heterogeneity test 1.3 (p-value = 0.015) 0.0 (p-value = 0.66) 
Leave-one-out meta-analysis, mean (country) 
Smallest 1.11 (Turkey) 1.05 (Argentina) 
Largest 1.86 (Peru) 1.18 (Colombia) 
 
Table 3: Estimated extra length of stay (LoS) and relative risk of death due to a nosocomial 
urinary tract infection stratified by Average Severity Illness Score (ASIS). The higher the 
ASIS score the sicker the patient. 
ASIS (categories) Admissions 
Total extra  
LoS, days  
Relative risk  
of death 
“Healthier” (1–3) 22,148 1.44 (–0.24, 3.12) 1.16 (0.96, 1.40) 
“Sicker” (4–5) 15,150 1.73 (0.64, 2.83) 1.04 (0.88, 1.23) 
Total 37,298   
 
 
  
Figure 1. Multi-state model used to estimate the time-dependent effect of nosocomial 
infection on length of stay and risk of death 
 
  
Figure 2. Extra length of stay in days due to a nosocomial urinary tract infection in each 
country and the overall extra length of stay from a meta-analysis. The squares are the mean 
estimates and the horizontal lines the 95% confidence intervals. The squares are inversely 
proportional to the standard error of the estimate. 
 
 
  
Figure 3. Relative risk of death due to a nosocomial urinary tract infection in each country 
and the overall relative risk from a meta-analysis. The relative risk axis is on a log scale. The 
squares are the mean estimates and the horizontal lines the 95% confidence intervals. The 
size of the squares is inversely proportional to the standard error of the estimate 
 
 
